Ectopic fat deposition and global cardiometabolic risk: new paradigm in cardiovascular medicine.
暂无分享,去创建一个
Daiju Fukuda | Chisayo Kozuka | M. Sata | Koichi Yabiku | M. Shimabukuro | Shin-ichiro Taira | K. Yamakawa | M. Higa | H. Masuzaki | S. Matsumoto | D. Fukuda | S. Yagi | Michio Shimabukuro | T. Soeki | Masataka Sata | Shusuke Yagi | Masayoshi Ishida | Takeshi Soeki | Chisayo Kozuka | Shin-ichiro Taira | Koichi Yabiku | Munkhbaatar Dagvasumberel | Masayoshi Ishida | Sachiko Matsumoto | Ken Yamakawa | Moritake Higa | Hisashi Yoshida | Hiroaki Masuzaki | M. Dagvasumberel | H. Yoshida
[1] 平良 伸一郎. Lipid deposition in various sites of skeletal muscle and liver shows positive correlation with visceral fat accumulation in middle-aged Japanese male patients with metabolic syndrome , 2013 .
[2] 中西 弘毅. Peri-atrial epicardial adipose tissue is associated with new-onset nonvalvular atrial fibrillation , 2013 .
[3] G. Lopaschuk,et al. Cellular cross-talk between epicardial adipose tissue and myocardium in relation to the pathogenesis of cardiovascular disease. , 2012, American journal of physiology. Endocrinology and metabolism.
[4] T. Wakatsuki,et al. Gender disparities in the association between epicardial adipose tissue volume and coronary atherosclerosis: A 3-dimensional cardiac computed tomography imaging study in Japanese subjects , 2012, Cardiovascular Diabetology.
[5] Jean-PierreDesprés. Body Fat Distribution and Risk of Cardiovascular Disease , 2012 .
[6] J. Després,et al. Body Fat Distribution and Risk of Cardiovascular Disease: An Update , 2012, Circulation.
[7] M. Szklo,et al. The Multi-Ethnic Study of Atherosclerosis (MESA) , 2012 .
[8] H. Sacks,et al. Human epicardial fat: what is new and what is missing? , 2011, Clinical and experimental pharmacology & physiology.
[9] John Spertus,et al. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. , 2011, Circulation.
[10] G. Iacobellis,et al. Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features , 2011, Trends in Endocrinology & Metabolism.
[11] Tetsuya Kitagawa,et al. Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. , 2011, Journal of the American College of Cardiology.
[12] T. Wadden,et al. Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes , 2011, Diabetes Care.
[13] R. Ross,et al. Cardiometabolic Risk in Canada: a Detailed Analysis and Position Paper by the Cardiometabolic Risk Working Group Introduction to the Concepts of Cardiometabolic Risk, Metabolic Syndrome, and Risk Stratification: Finding the Forest among the Trees E2 , 2022 .
[14] G. Bray,et al. The Relationship of Waist Circumference and BMI to Visceral, Subcutaneous, and Total Body Fat: Sex and Race Differences , 2011, Obesity.
[15] D. Wilber,et al. Pericardial fat is independently associated with human atrial fibrillation. , 2010, Journal of the American College of Cardiology.
[16] S. Shioda,et al. Endovascular Injury Induces Rapid Phenotypic Changes in Perivascular Adipose Tissue , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[17] Udo Hoffmann,et al. Pericardial Fat Is Associated With Prevalent Atrial Fibrillation: The Framingham Heart Study , 2010, Circulation. Arrhythmia and electrophysiology.
[18] Moyses Szklo,et al. The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2009, The American journal of clinical nutrition.
[19] M. Shimabukuro. Cardiac adiposity and global cardiometabolic risk: new concept and clinical implication. , 2009, Circulation journal : official journal of the Japanese Circulation Society.
[20] Philippe Pibarot,et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[21] D. Roden,et al. Metabolic Syndrome and Risk of Development of Atrial Fibrillation: The Niigata Preventive Medicine Study , 2008, Circulation.
[22] Udo Hoffmann,et al. Pericardial Fat, Visceral Abdominal Fat, Cardiovascular Disease Risk Factors, and Vascular Calcification in a Community-Based Sample: The Framingham Heart Study , 2008, Circulation.
[23] A. Selwyn. Weight reduction and cardiovascular and metabolic disease prevention: clinical trial update. , 2007, The American journal of cardiology.
[24] L. Orci,et al. Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America. , 2007, Circulation research.
[25] J. Després,et al. Obesity and Metabolic Syndrome Are Independent Risk Factors for Atrial Fibrillation After Coronary Artery Bypass Graft Surgery , 2007, Circulation.
[26] Mahbubur Rahman,et al. Impact of Metabolic Syndrome on the Development of Cardiovascular Disease in a General Japanese Population: The Hisayama Study , 2007, Stroke.
[27] X. Jouven,et al. Contribution of the metabolic syndrome to sudden death risk in asymptomatic men: the Paris Prospective Study I. , 2007, European heart journal.
[28] G. Bray,et al. Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes , 2007, Diabetes Care.
[29] A. Moss,et al. Obesity As a Risk Factor for Sustained Ventricular Tachyarrhythmias in MADIT II Patients , 2007, Journal of cardiovascular electrophysiology.
[30] A. Bradbury,et al. Obesity and thrombosis. , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[31] F. Schick,et al. High Visceral Fat Mass and High Liver Fat Are Associated with Resistance to Lifestyle Intervention , 2007, Obesity.
[32] S. Grundy. Controversy in Clinical Endocrinology Metabolic Syndrome: a Multiplex Cardiovascular Risk Factor Mets as a Multiplex Cardiovascular Risk Factor , 2022 .
[33] J. Obata,et al. High prevalence of paroxysmal atrial fibrillation and/or atrial flutter in metabolic syndrome. , 2007, Circulation journal : official journal of the Japanese Circulation Society.
[34] Parvez Hossain,et al. Obesity and diabetes in the developing world--a growing challenge. , 2007, The New England journal of medicine.
[35] R. Gropler,et al. Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass. , 2006, European heart journal.
[36] N. Takasu,et al. Vascular lipotoxicity: endothelial dysfunction via fatty-acid-induced reactive oxygen species overproduction in obese Zucker diabetic fatty rats. , 2007, Endocrinology.
[37] S. Kahn,et al. Review: The role of insulin resistance in nonalcoholic fatty liver disease. , 2006, The Journal of clinical endocrinology and metabolism.
[38] K. Node,et al. Vascular failure: a new clinical entity for vascular disease , 2006, Journal of hypertension.
[39] P. Iozzo,et al. Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. , 2006, The Journal of clinical endocrinology and metabolism.
[40] S. Svacina,et al. Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. , 2006, The Journal of clinical endocrinology and metabolism.
[41] T. Funahashi,et al. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. , 2006, Circulation journal : official journal of the Japanese Circulation Society.
[42] V. Davutoglu,et al. Uncomplicated Metabolic Syndrome Is Associated with Prolonged Electrocardiographic QTc Interval and QTc Dispersion , 2006, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.
[43] A. Folsom,et al. Risk Factors for Ischemic Stroke Subtypes: The Atherosclerosis Risk in Communities Study , 2006, Stroke.
[44] Kohjiro Ueki,et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. , 2006, The Journal of clinical investigation.
[45] E. Ingelsson,et al. Metabolic syndrome and risk for heart failure in middle-aged men , 2006, Heart.
[46] Ajay M Shah,et al. Oxidative stress and redox signalling in cardiac hypertrophy and heart failure , 2006, Heart.
[47] M. Zou,et al. Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. , 2006, The Journal of clinical investigation.
[48] E. Ingelsson,et al. Novel metabolic risk factors for heart failure. , 2005, Journal of the American College of Cardiology.
[49] G. Targher,et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. , 2005, Diabetes.
[50] P. Meda,et al. Production of Chemokines by Perivascular Adipose Tissue: A Role in the Pathogenesis of Atherosclerosis? , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[51] Richard Kahn,et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. , 2005, Diabetes care.
[52] R. Kahn,et al. The metabolic syndrome: time for a critical appraisal , 2005, Diabetologia.
[53] Ildikó Kriszbacher,et al. Inflammation, atherosclerosis, and coronary artery disease. , 2005, New England Journal of Medicine.
[54] J. McGavock,et al. Determination of triglyceride in the human myocardium by magnetic resonance spectroscopy: reproducibility and sensitivity of the method. , 2005, American journal of physiology. Endocrinology and metabolism.
[55] C. Stehouwer,et al. “Vasocrine” signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease , 2005, The Lancet.
[56] S. Olshansky,et al. A potential decline in life expectancy in the United States in the 21st century. , 2005, The New England journal of medicine.
[57] R. Brandes,et al. Vascular NADPH oxidases: molecular mechanisms of activation. , 2005, Cardiovascular research.
[58] Morihiro Matsuda,et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. , 2004, The Journal of clinical investigation.
[59] Steven Hawken,et al. Preventive cardiologyAbstractsEffect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study , 2004 .
[60] Fritz Schick,et al. Intrahepatic lipids are predicted by visceral adipose tissue mass in healthy subjects. , 2004, Diabetes care.
[61] D. Harrison,et al. Redox Mechanisms in Blood Vessels , 2004 .
[62] S. Yusuf,et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.
[63] H. Tunstall-Pedoe,et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.
[64] G. Metzger,et al. Myocardial triglycerides and systolic function in humans: In vivo evaluation by localized proton spectroscopy and cardiac imaging , 2003, Magnetic resonance in medicine.
[65] Douglas W Mahoney,et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. , 2003, JAMA.
[66] R. Unger,et al. Lipotoxic diseases. , 2002, Annual review of medicine.
[67] B. Goodpaster,et al. Muscle triglyceride and insulin resistance. , 2002, Annual review of nutrition.
[68] J. Marrugat,et al. Relationship of obesity distribution and peripheral arterial occlusive disease in elderly men , 2000, International Journal of Obesity.
[69] M. Samama,et al. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. , 2000, Archives of internal medicine.
[70] S. O’Rahilly,et al. The perils of portliness: causes and consequences of visceral adiposity. , 2000, Diabetes.
[71] L. Orci,et al. Lipotoxic heart disease in obese rats: implications for human obesity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[72] T. Funahashi,et al. Molecular Mechanism of Metabolic Syndrome X: Contribution of Adipocytokines · Adipocyte‐derived Bioactive Substances , 1999, Annals of the New York Academy of Sciences.
[73] L. Wilhelmsen,et al. Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: "the study of men born in 1913". , 1999, Archives of internal medicine.
[74] R. Ross,et al. Atherosclerosis is an inflammatory disease. , 1998, American heart journal.
[75] L. DiPietro,et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study , 1999, Diabetologia.
[76] R. Unger,et al. Fatty acid-induced β cell apoptosis: A link between obesity and diabetes , 1998 .
[77] D. Harrison,et al. Cellular and molecular mechanisms of endothelial cell dysfunction. , 1997, The Journal of clinical investigation.
[78] R. Unger,et al. Role of nitric oxide in obesity-induced beta cell disease. , 1997, The Journal of clinical investigation.
[79] C. Newgard,et al. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[80] G. Lowe,et al. The relationship between cigarette smoking and cardiovascular risk factors in peripheral arterial disease compared with ischaemic heart disease. The Edinburgh Artery Study. , 1995, European heart journal.
[81] P. Elwood,et al. Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study. , 1994, British heart journal.
[82] 小谷 一晃. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese , 1994 .
[83] M J Shipley,et al. Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study. , 1990, Circulation.